Find a TenderAwarded without competition
Published 19 Jun 2026, 15:04 BST

Official UK procurement notice

Stem Cell and Immunotherapy Services

Official notice

Authority: The Newcastle Upon Tyne Hospitals NHS Foundation Trust (Central government)

GoodsAward procedure without prior publication of a call for competition
Budget not disclosedValue not published
Awarded 19 Jun 2026no call for competition
Awarded to NHS BLOOD AND TRANSPLANT (NHSBT)

What is being bought

Published requirement description

Stem Cell and Immunotherapy Services

CPV: Blood-transfusion supplies

The lotProcurement structure

single lot · no lot value published

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Award procedure without prior publication of a call for competition
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
19 Jun 2026, 15:04 BST
Last source update
19 Jun 2026, 15:04 BST
FTS notice number
2026/S 000-058186
Classification (CPV)
Blood-transfusion supplies
Delivery area
North East (UKC2)
Official registry OCID
ocds-h6vhtk-06b961 Find a Tender
Why no open competition
The procurement falls outside the scope of application of the directive
Published justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award.

Publisher note: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. Representations by providers must be made to The Newcastle upon Tyne Hospitals NHS Foundation Trust at the following email address: [email protected] Details of the award decision-makers: The decision to award was made by an MDT consisting of representatives from Finance, Clinical Board and Procurement. Declarations of Interest were sought from the members of the MDT prior to consideration of contract award. No declarations of interest were declared. The provider was assessed against 5 key criteria: Quality and Innovation; Value; Integration, collaboration, and service sustainability; Improving access, reducing inequalities, and facilitating choice; and social value. Each criterion was assessed on a pass/fail basis, considering whether they have currently satisfied the criteria under the previous contract and whether they would likely satisfy the criteria under the previous contract and whether they would likely satisfy the proposed contract to a sufficient standard. The provider achieved a pass score against all criteria.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Bids received 1
Contracts signed 1latest 19 Jun 2026
Awarded toValueDateStatus
NHS BLOOD AND TRANSPLANT (NHSBT)SME——Awarded

Contracts

Bid statistics published by the authority

BidsSMEVCSEValid bid range
1bids · 1 electronic · 1 from abroad0—£284,201 – £284,201

Contracting authority & participating public bodies

The Newcastle Upon Tyne Hospitals NHS Foundation Trust

Contracting authorityCentral GovernmentHealth CareHealth Freeman Hospital, Freeman Road, High Heaton, Newcastle-upon-Tyne, North East, NE7 7DNContact name, email, phone

Bidders & participating suppliers

1 commercial party on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.